Literature DB >> 21243306

Clinical relevance and frequency of cytoplasmic and nuclear dense fine speckled patterns observed in ANA-HEp-2.

Andréia Martini Pazini1, Juliana Fleck, Rosane Souza dos Santos, Sandra Trevisan Beck.   

Abstract

OBJECTIVES: This study aimed to determine the frequency and antibody titers of nuclear dense fine and cytoplasmic patterns with possible clinical correlation.
METHODS: From 2007 to 2009, the results of 2,788 autoantibody serological tests were assessed by indirect immunofluorescence (IIF) at LAC-HUSM/UFSM, using as substrate HEp-2.
RESULTS: Among the analyzed samples, 1,998 of them were negative for autoantibodies. Among the positive samples (n = 790), we found 57 (7.2%) showing reactivity pattern described as dense fine speckled (DFS) (3.8%), or cytoplasmic (Cit) fluorescence (3.4%). In samples with standard DFS (n = 29), nine had titers of 1/160, and only one patient had autoimmune disease (AID). Among patients with titers > 1/160, only one patient did not have AID. Among samples with standard Cit (n = 27), 20 had titers of 1/160, and only eight were not associated with AID. The other seven patients with titers > 1/160 reported AID.
CONCLUSION: The results confirm the value of 1/160 as the best cut-off point for defining AID presence, for any of the fluorescence assessed patterns. However, attention should be given to lower titers, especially for Cit IIF, since only 40% did not report the presence of AID.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21243306

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN: 0482-5004


  8 in total

Review 1.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

2.  The Prevalence and Clinical Relevance of the DFS Immunofluorescence Staining Pattern in a Large ANA-Positive Cohort.

Authors:  Chuiwen Deng; Anqi Wang; Chaojun Hu; Wen Zhang; Xiaofeng Zeng; Yunyun Fei
Journal:  Front Med (Lausanne)       Date:  2022-05-10

Review 3.  [Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70].

Authors:  R Mierau
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

Review 4.  The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.

Authors:  Robert L Ochs; Michael Mahler; Anamika Basu; Leslimar Rios-Colon; Tino W Sanchez; Luis E Andrade; Marvin J Fritzler; Carlos A Casiano
Journal:  Clin Exp Med       Date:  2015-06-19       Impact factor: 3.984

5.  Analysis of DFS70 pattern and impact on ANA screening using a novel HEp-2 ELITE/DFS70 knockout substrate.

Authors:  Kishore Malyavantham; Lakshmanan Suresh
Journal:  Auto Immun Highlights       Date:  2017-03-17

6.  Recognition and Relevance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital.

Authors:  John B Carter; Sara Carter; Sandra Saschenbrecker; Bruce E Goeckeritz
Journal:  Front Med (Lausanne)       Date:  2018-04-09

7.  Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate.

Authors:  Kishore S Malyavantham; Lakshmanan Suresh
Journal:  J Vis Exp       Date:  2018-01-17       Impact factor: 1.355

8.  Prevalence and serological profile of anti-DFS70 positive subjects from a routine ANA cohort.

Authors:  Teresa Carbone; Vito Pafundi; Giuseppina Tramontano; Michele Gilio; Maria Carmela Padula; Angela Anna Padula; Salvatore D'Angelo
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.